Clinical Trial: Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
Study Status: Completed
Recruit Status: RECRUITING
Condition: Sickle Cell Disease
Study Type: INTERVENTIONAL
Official Title: Non-myeloablative Phase I/II Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
Brief Summary:
Background:Sickle cell disease (SCD) is a genetic disorder where red blood cells, that carry oxygen, are stiff and become stuck in small blood vessels.As a result, affected patients can experience severe pain and serious organ damage.SCD can be cured with a hematopoietic cell transplant (HCT), that is, when they receive blood stem cells from a family donor.But HCT can also have serious side effects, especially in people with organ damage.Researchers want to find ways to make HCT safer for everyone.Objective:To…
Read more